Description

Combining two SSRIs is generally contraindicated due to markedly elevated serotonin syndrome risk and no additional therapeutic benefit.

Mécanisme

Both agents inhibit SERT-mediated serotonin reuptake; concurrent use produces additive serotonin accumulation in central synapses.

Signification clinique

Dual SSRI therapy provides no clinical advantage over monotherapy and substantially raises serotonin toxicity risk.

Prise en charge

Avoid concurrent use; when switching SSRIs, allow an appropriate washout period (5 half-lives of the discontinued drug).

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.